MYOV phase-3 endometriosis results tomorrow morning: https://www.globenewswire.com/news-release/2020/06/22/2051560/0/en/Myovant-Sciences-to-Host-Webcast-and-Conference-Call-at-8-30-am-Eastern-Time-Tuesday-June-23-to-Discuss-Results-from-Phase-3-SPIRIT-1-Study-Evaluating-Once-Daily-Relugolix-Combinat.html